Generic APIs
 Generic Products
 cGMP Manufacturing Facilities
 cGMP Production Capabilities
 cGMP Analytical Capabilities
 Regulatory Affairs
 Service and Partnership
 
 peptide and neuropeptide  WHAT'S NEW
 peptide and neuropeptide  ONLINE CATALOG
 peptide and neuropeptide  CUSTOM SYNTHESIS
 peptide and neuropeptide  ANALYTICAL DATA SHEET (ADS)
 peptide and neuropeptide  SERVICES
 peptide and neuropeptide  TECHNICAL LIBRARY
 peptide and neuropeptide  DOCUMENTS
 peptide and neuropeptide  SITEMAP
 peptide and neuropeptide  JOBS
 peptide and neuropeptide  CONTACT
   BOOKMARK & SHARE
  © Bachem AG
Enfuvirtide    
 
4062235
CAS No. 159519-65-0
Synonyms
T20; Pentafuside
Sequence
Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2

Fields of application
Treatment of human immunodeficiency virus type 1 (HIV-1) infection. Enfuvirtide is used in combination with other antiretroviral agents in therapy-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.

Active substance
Enfuvirtide is a 36 amino acid peptide corresponding to a region of gp41, the transmembrane subunit of HIV-1 envelope protein. It belongs to the therapeutic class of fusion inhibitors and acts by binding to gp41 and impeding the conformational changes in gp41 necessary for fusion of the virus with the cell.


This product is offered and sold solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use or sale of drugs (the “Bolar Exemption”). Bachem cannot be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of this product to comply with the relevant national rules and regulations.
please send me a quote

To view the full list of Generic APIs click here.



 Back to
 Generic Products